Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines

European Journal of Medicinal Chemistry

Volumn 42, Issue 1, 2007, Pages 30-36

  Karthikeyan, Mari Sithambaram ^a   Holla, Bantwal Shivarama ^a   Kumari, Nalilu Suchetha ^b  

^a MANGALORE UNIVERSITY   (India)

^b NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

2,4 Dichloro 5 fluorophenyl chalcones; Antibacterial activity; Antifungal activity; Hydroxy pyrazolines

Indexed keywords

BROMIDE; CHALCONE DERIVATIVE; CHLORINE DERIVATIVE; FLUORINE DERIVATIVE; HYDRAZIDE; HYDROXYL GROUP; PYRAZOLINE DERIVATIVE; TRIETHYLAMINE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CLAISEN CONDENSATION; CULTURE MEDIUM; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; INFRARED SPECTROSCOPY; KLEBSIELLA PNEUMONIAE; MELTING POINT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIUM MARNEFFEI; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; REACTION ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; STRUCTURE ANALYSIS; TRICHOPHYTON MENTAGROPHYTES;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; CHALCONES; COLONY COUNT, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MITOSPORIC FUNGI; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33846651520     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2006.07.011     Document Type: Article

References (21)

1. Geiger W.B., and Conn J.E. J. Am. Chem. Soc. 67 (1945) 112-116
2. Marian D.H., Russel P.B., and Todd A.R. J. Chem. Soc. (1947) 1412
3. Ambekar S., Venekar S.S., Acharya S., and Rajagopal S. J. Pharm. Pharmacol. 13 (1961) 698-699
4. Cole W., and Julian P.L. J. Org. Chem. 19 (1954) 131-138
5. Main L., and Old K.B. Tetrahedron Lett. (1977) 2809-2810
6. Taylor E.C., Patel H., and Kumar H. Tetrahedron 48 (1992) 8089-8100
7. Lombardino J.G., and Otterness I.G. J. Med. Chem. 20 (1977) 830-834
8. Holla B.S., Akberali P.M., and Shivananda M.K. Il Farmaco 55 (2000) 256-263
9. Bansal E., Srivatsava V.K., and Kumar A. Eur. J. Med. Chem. 36 (2001) 81-92
10. Manna F., Chimenti F., Fioravanti R., Bolasco A., Seecci D., Chimenti P., Ferlini C., and Scambia G. Bioorg. Med. Chem. Lett. 15 (2005) 4632-4635
11. Ahn J.H., Kim H.M., Jung S.H., Kang S.K., Kim K.R., Rhee S.D., Yang S.D., Cheon H.G., and Kim S.S. Bioorg. Med. Chem. Lett. 14 (2004) 4461-4465
12. Rajendera Prasad Y., Lakshmana Rao A., Prasoona L., Murali K., and Ravi Kumar P. Bioorg. Med. Chem. Lett. 15 (2005) 5030-5034
13. Mulder R., Wellinga K., and Van Daalen J.J. Naturwissenschaften 62 (1975) 531-532
14. Strunecka A., Patocka J., and Connett P. J. Appl. Biomed. 2 (2004) 141-150
15. Kevin Park B., Kitteringham N.R., and O'Neill P.M. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 443-470
16. Sachchar S.P., and Singh A.K. J. Ind. Chem. Soc. 62 (1985) 142
17. Cruickshank R., Duguid J.P., Marion B.P., and Swain R.H.A. Medicinal Microbiology. Twelfth ed. vol. II (1975), Churchil Livingstone, London pp. 196-202
18. In: Collins A.H. (Ed). Microbiological Methods. second ed. (1976), Butterworth, London
19. Z.K. Khan, In vitro and vivo screening techniques for bioactivity screening and evaluation, in: Proceeding Int. Workshop UNIDO-CDRI, 1997, pp. 210-211.
20. In: Varma R.S. (Ed). Antifungal Agents: Past, Present and Future Prospects (1998), National Academy of Chemistry & Biology, India, Lucknow
21. B.S. Rao, Ph.D thesis, Unpublished work.